The global vitamin D testing market is poised for substantial growth, with expectations to surge from US$ 917.55 million in 2023 to US$ 1,999.35 million by 2033, according to recent market analyses. This represents a robust compound annual growth rate (CAGR) of 8.1%, signaling a significant expansion driven by enhanced awareness of vitamin D’s health benefits and technological advancements in testing methods.
Vitamin D, often referred to as the “sunshine vitamin”, is crucial for bone health, immune function, and other vital physiological processes. Given its importance, the industry has seen an uptick in demand for vitamin D testing, which helps in assessing an individual’s nutritional status and detecting potential deficiencies or excesses.
Request A Sample Copy of This Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-16906
Historically, the most reliable indicator of vitamin D status has been the measurement of 25-hydroxyvitamin D [25(OH)D] in the blood. The market offers various testing methodologies, including immunoassays, which are favored for their cost-effectiveness and simplicity, and liquid chromatography-mass spectrometry (LC-MS), recognized as the gold standard due to its high accuracy and precision.
“The growing understanding of vitamin D’s role in disease prevention and health promotion has been a primary catalyst for market growth,” says FMI. “Additionally, an increase in routine vitamin D screenings, driven by an aging population and the higher prevalence of chronic conditions such as osteoporosis, underscores the market’s expansion.”
The market for vitamin D testing is analyzed across various segments, including test type, end-user, and geography. Test types are categorized into 25(OH)D2 and 25(OH)D3, with end-users ranging from hospitals and clinical laboratories to research institutes. Geographically, the market is segmented into key regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa, with each region showing unique growth dynamics.
This growth trajectory is supported by ongoing research and development in the field, aiming to make vitamin D testing more accessible and accurate, thereby enabling better health management for consumers worldwide.
Key Takeaways:
- In 2018, China expanded at a market value of US$ 38.4 billion in the vitamin D testing market. The market is expected to reach US$ 74.9 million in 2023.
- The vitamin D testing market was significantly expanding, with a size of US$ 848.8 billion in 2022.
- The market is anticipated to reach a valuation of US$ 1,159.08 million by 2026, as a result of emerging cloud-based platforms.
- Due to the market’s excellent potential and utilization of smartphones in testing, analysts expect it is likely to rise 1.08 times between 2022 and 2023.
- As demand for preventive healthcare solutions rises, the United Kingdom market is expected to develop at a prodigious CAGR by 2033.
- Based on product type, the 25-hydroxy vitamin D test dominated the market in 2022 and continued to lead the market during the forecast period.
- Based on indications, osteoporosis led the market in 2022 and continues to lead the market during the forecast period.
- The LC-MS segment dominated the market in 2022 and is likely to hold the top spot throughout the projected period.
- Based on patient category, adult patients led the market in 2022 and continues to lead during the forecast period
Methodology Details Just a Click Away: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-16906
Critical Approaches Increasing Top Players’ Wealth:
Due to a few dominant competitors controlling the bulk of market shares, the vitamin D testing industry is consolidated in nature. One of the primary reasons for market dominance is the development of cutting-edge modern technologies that give patients precise outcomes.
Recent Developments:
- In order to increase the presence of its brand, Thermo Fisher Scientific Inc. made declared in March 2020. The Cascadion SM Clinical Analyzer for the Cascadion SM 25-hydroxy vitamin D assay is now offered in the United States.
- In January 2022, F. Hoffmann-La Roche Ltd. released Cobas Infinity Edge. It is a cloud-based platform for integrating and managing point-of-care data that can be used in clinical settings anywhere in the world.
Key Players:
- Abbott
- F. Hoffmann-La Roche Ltd
- BIOMÉRIEUX
- Thermo Fisher Scientific Inc.
- Danaher
- Siemens Healthineers AG
- DiaSorin S.p.A.
- Beckman Coulter, Inc. (BD)
- Tosoh Bioscience, Inc.
- Quest Diagnostics Incorporated.
Direct Purchase of this Report: https://www.futuremarketinsights.com/checkout/16906
Key Segments:
Vitamin D Testing By Product:
- 25-Hydroxy Vitamin D Testing
- 1,25-Dihydroxy Vitamin D Testing
Vitamin D Testing by Indication:
- Vitamin D Testing for Osteoporosis
- Vitamin D Testing for Rickets
- Vitamin D Testing for Thyroid Disorders
- Vitamin D Testing for Vitamin D Deficiency
- Others
Vitamin D Testing by Technology:
- Radioimmunoassay
- ELISA
- HPLC
- LC-MS
- Others
Vitamin D Testing by Patient:
- Vitamin D Testing in Adult
- Vitamin D Testing in Pediatric
Vitamin D Testing by Test Location:
- Vitamin D Testing at Point-of-Care
- Others
Vitamin D Testing by End-use:
- Vitamin D Testing for Hospitals
- Vitamin D Testing for Diagnostic Laboratories
- Vitamin D Testing for Homecare
- Others
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
